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The present study. Kaski et al. (1) in this issue of the 
Journal conclude that "rest baseline coronary tone and the 
vasomotor response of angiographically normal coronary 
artery segments to ergonovine and isosorbide dinitrate are 
similar in patients with noncardiac chest pain, Prinzmetal's 
variant angina and coronary artery disease. " However, their 
findings differ in several respects from our observations (2). 
In the study of Kaski et al. (1), the control coronary 
artery diameter calculated for the vasodilation induced by 
nitrate is used to calculate the diameter obtained 5 to 7 min 
after administration of ergonovine. It has been reported (3) 
that after intravenous ergonovine injection, the half-life of 
the disappearance phase ranges from 32 to 116 min. Signif-
icant coronary diameter reduction induced by ergonovine 
seems to remain at 5 to 7 min. Therefore, baseline diameter 
or diameter before ergonovine administration should be used 
as a control for the evaluation of the effect of nitrate when 
trying to quantify the degree of basal coronary tone. Thus, 
the percent of vasodilation calculated by using baseline 
diameter is properly less than that found in the present 
study. Kaski et al. (1) observe that the extent of vasodilation 
in our patients with vasospastic angina was much larger than 
that reported in western patients, but that the extent of 
vasodilation in our nonangina group was less than that 
observed by other investigators. However, the extent of 
vasodilation observed in proximal nonspastic segments in 
the current study of Kaski et al. is less than that they have 
reported previously (4). Furthermore, the extent of vasodi-
lation in their control patients is less than that observed in 
our patients (2). 
Reasons for differences in results. Although data on the 
coronary artery (right, left or both) in which nitrate was 
injected and the actual measurement site (arteries without 
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spasm or adjacent segments) are not presented by Kaski et 
al. (1), other causes of reduced vasodilation may be a lower 
dose of nitrate and the difference in doses and routes for 
ergonovine administration (8 to 20 p,g for intracoronary 
injection and 100 to 300 p,g for intravenous injection). The 
discrepancy between our results (2) and those of Kaski et al. 
(1) may be due to the differences in the number of patients 
studied and patient selection. In their study (1), systemic 
hypertension and cardiomyopathy were excluded from the 
control group, whereas we included patients with these 
diagnoses. There is a possibility that the extent of vasodila-
tion induced by nitrate is less in patients with cardiomyop-
athy than in other control patients. Although the present 
study (1) does not describe whether six patients with 
significant stenoses had coronary spasm at the site with 
a significant stenosis, the possibility cannot be excluded 
that there is less coronary response to ergonovine and 
nitrate in patients with than in those without significant 
stenosis. There are no reports that contradict the geometric 
theory of MacAlpin (5) in patients with severe coronary 
stenosis. 
As indicated by Kaski et al. (1), the discrepancies may 
also result from ethnic differences. Kurimoto et al. (6) 
reported that the basal coronary tone is higher in patients 
with rest angina. We (7) have shown that the greater is the 
extent of generalized vasodilation induced by nitrate, the 
greater is the extent of localized and maximal vasoconstric-
tion induced by ergonovine. 
Interaction between coronary artery tone and spasm. Cor-
0nary artery spasm is usually associated with an atheroscle-
rotic lesion. Vanhoutte et al. (8) speculated that the vaso-
constriction or coronary spasm induced by ergonovine is 
significantly enhanced in coronary arteries with endothelial 
dysfunction. Recently, after studying responses of human 
coronary artery to intracoronary injection of acetylcholine, 
Yasue et al. (9) suggested that all coronary arteries in 
patients with variant angina are affected by endothelial 
injury or atherosclerosis, even though some of these arteries 
may appear normal angiographically. Thus, this diffuse 
atherosclerosis and endothelial dysfunction may playa ma-
jor role in the pathogenesis of coronary spasm. It is easy to 
speculate that the generalized increase in basal coronary 
tone may reflect abnormal vasoconstriction with diffuse 
endothelial injury or dysfunction induced by various intrin-
sic stimuli. 
Conclusions. MacAlpin (5) suggested that coronary spasm 
is the result of physiologic vasomotion at the site of organic 
stenosis. We speculated that the change in generalized basal 
coronary tone may be part of the cause of coronary spasm. 
However, the generalized basal coronary tone is increased 
beyond the physiologic limits. We believe that the occurrence 
of coronary spasm requires a localized disorder in addition to 
increased basal tone reflected by abnormal vasoconstriction 
induced by various intrinsic stimuli. 
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